SavedAdd your journal

Journals / Ulusal Travma ve Acil Cerrahi Dergisi / 2022 / Cilt: 28 - Sayı: 8

Risk factors for mortality in Fournier’s gangrene of anorectal origin

Yasin Tosun
Ozan Akıncı
Hasan Fehmi Küçük
Pages
1128–1133
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the non-survival group, rate of smoking, diabetes mellitus, malignancy and other chronic diseases, and mean age, duration of symptoms at admission, number of debridements, SFGSI, FGSI, white blood cells, and creatinine were significantly higher, while hematocrit, serum potassium, and albumin levels were significantly lower (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND: In the present study, we aimed to determine the risk factors for mortality in Fournier’s gangrene (FG), which has a high morbidity and mortality rate and requires urgent surgical intervention.
📊
Key Findings & Data:METHODS: A retrospective analysis was made of 150 patients who were operated on in our clinic due to FG of anorectal origin be- tween 2010 and 2020.
💡
Conclusion & Impact:In the non-survival group, rate of smoking, diabetes mellitus, malignancy and other chronic diseases, and mean age, duration of symptoms at admission, number of debridements, SFGSI, FGSI, white blood cells, and creatinine were significantly higher, while hematocrit, serum potassium, and albumin levels were significantly lower (p
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

BACKGROUND: In the present study, we aimed to determine the risk factors for mortality in Fournier’s gangrene (FG), which has a high morbidity and mortality rate and requires urgent surgical intervention. METHODS: A retrospective analysis was made of 150 patients who were operated on in our clinic due to FG of anorectal origin be- tween 2010 and 2020. The cases were divided into survival and non-survival groups. Demographic, clinical, laboratory, and treatment data, FG Severity Index (FGSI), and simplified FGSI (SFGSI) scores were analyzed. RESULTS: Thirty-day mortality rate was 15.3%. In the non-survival group, rate of smoking, diabetes mellitus, malignancy and other chronic diseases, and mean age, duration of symptoms at admission, number of debridements, SFGSI, FGSI, white blood cells, and creatinine were significantly higher, while hematocrit, serum potassium, and albumin levels were significantly lower (p

🔖

Cite This Article

Tosun, Y., Akıncı, O., Küçük, H. F. (2022). Risk factors for mortality in Fournier’s gangrene of anorectal origin. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 28 - Sayı: 8, 1128–1133. https://ajindex.com/articles/643979

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. El-Qushayri AE, Khalaf KM, Dahy A, Mahmoud AR, Benmelouka AY, Ghozy S, et al. Fournier’s gangrene mortality: A 17-year systematic re- view and meta-analysis. Int J Infect Dis 2020;92:218–25
  2. Singh A, Ahmed K, Aydin A, Khan MS, Dasgupta P. Fournier’s gan- grene. A clinical review. Arch Ital Urol Androl 2016;88:157–64
  3. Chennamsetty A, Khourdaji I, Burks F, Killinger KA. Contempo- rary diagnosis and management of Fournier’s gangrene. Ther Adv Urol 2015;7:203–15
  4. Tenorio CE, Lima SV, Albyquerque AV, Cavalcanti MP, Teles F. Risk factors for mortality in Fournier’s gangrene in a general hospital: Use of simplified Fournier Gangrene Severe Index Score (SFGSI). Int Braz J Urol 2018;44:95–101
  5. Eke N. Fournier’s gangrene: A review of 1726 cases. Br J Surg 2000;87:718–28
  6. Sorensen MD, Krieger JN. Fournier’s Gangrene: Epidemiology and Out- comes in the General US Population. Urol Int 2016;97:249–59
  7. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier’s gangrene. J Urol 1995;154:89–92
  8. Corcoran AT, Smaldone MC, Gibbons EP, Walsh TJ, Davies BJ. Vali- dation of the Fournier’s gangrene severity index in a large contemporary series. J. Urol 2008;180:944–8
  9. Yilmazlar T, Ozturk E, Ozguc H, Ercan I, Vuruskan H, Oktay B. Fourni- er’s gangrene: An analysis of 80 patients and a novel scoring system. Tech Coloproctol 2010;14:217–23
  10. Lin TY, Ou CH, Tzai TS, Tong YC, Chang CC, Cheng HL, et al. Valida- tion and simplification of Fournier’s Gangrene Severity Index. Int J Urol 2014;21:696–701
  11. Barupal SR, Soni ML, Barupal R. Factors Affecting Mortality Following Necrotizing Soft-Tissue Infections: Randomized Prospective Study. J Emerg Trauma Shock 2019;12:108–16
  12. Vyas HG, Kumar A, Bhandari V, Kumar N, Jain A, Kumar R. Prospec- tive evaluation of risk factors for mortality in patients of Fournier’s gan- grene: A single center experience. Indian J Urol 2013;29:161–5
  13. Luján Marco S, Budía A, Di Capua C, Broseta E, Jiménez Cruz F. Eval- uation of a severity score to predict the prognosis of Fournier’s gangrene. BJU Int 2010;106:373–6
  14. Jimenez-Pacheco A, Arrabal-Polo MA, Arias-Santiago S, Arrabal-Mar- tin M, Nogueras-Ocana M, Zuluaga-Gomez A. Fournier gangrene: De- scription of 37 cases and analysis of associated health care costs. Actas Dermosifiliogr 2012;103:29–35
  15. Nisbet AA, Thompson IM. Impact of diabetes mellitus on the presenta- tion and outcomes of Fournier’s gangrene. Urology 2002;60:775–9